The PulsePoint Study

Summary

This randomized controlled trial will evaluate whether use of the PulsePoint system increases bystander CPR or defibrillator use compared to standard dispatch procedures in patients who suffer non-traumatic, out-of-hospital cardiac arrest in a public location. Half of all suspected cardiac arrest 9-1-1 calls in a public location will receive PulsePoint alerts (treatment arm). The other half of this eligible patient cohort will receive standard dispatch procedures (control arm).

Conditions

• Out-Of-Hospital Cardiac Arrest
• Heart Arrest
• Heart Diseases
• Cardiovascular Diseases

Interventions

OTHER

PulsePoint notification

The PulsePoint interface software monitors each 9-1-1 call on dispatch computers and is automatically triggered by particular conditions including call type (e.g. suspected cardiac arrest) and location type (public location). When triggered, the system pushes location data to all PulsePoint mobile application users within 400 meters of the emergency location. When a mobile device running the PulsePoint Respond application receives the alert data from the PulsePoint system, the device alarms with auditory, tactile (vibration) and visual stimuli. The application presents a map showing the exact location of the suspected cardiac arrest and the closest public access defibrillator.

Sponsors & Collaborators

• University of British Columbia

  collaborator OTHER

• BC Emergency Health Services

  collaborator UNKNOWN

• Winnipeg Fire Paramedic Service

  collaborator UNKNOWN

• University of Manitoba

  collaborator OTHER

• University of Toronto

  collaborator OTHER

• Ohio State University

  collaborator OTHER

• Columbus Division of Fire

  collaborator UNKNOWN

• PulsePoint Foundation

  collaborator UNKNOWN

• Dr. Steven Brooks

  lead OTHER

Principal Investigators

• Steven C Brooks, MD MHSc · Queen's University

• John M Tallon, MD MSc · University of British Columbia

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

TRIPLE

Model

PARALLEL

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-06-08

Primary Completion

2026-03-27

Completion

2026-06-30

Countries

• United States
• Canada

Study Locations